Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,583 | 792 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,615 | 87 | $0 (2024) |
| Lilly USA, LLC | $1,339 | 109 | $0 (2024) |
| ABBVIE INC. | $1,302 | 100 | $0 (2024) |
| GlaxoSmithKline, LLC. | $840.69 | 66 | $0 (2024) |
| PFIZER INC. | $752.96 | 51 | $0 (2024) |
| Novo Nordisk Inc | $701.92 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $562.81 | 43 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $530.94 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $511.78 | 37 | $0 (2023) |
| Amgen Inc. | $492.62 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,030 | 116 | AstraZeneca Pharmaceuticals LP ($494.43) |
| 2023 | $1,986 | 135 | ABBVIE INC. ($373.68) |
| 2022 | $1,947 | 139 | ABBVIE INC. ($341.72) |
| 2021 | $1,438 | 99 | AbbVie Inc. ($278.93) |
| 2020 | $1,261 | 89 | Amarin Pharma Inc. ($176.16) |
| 2019 | $1,046 | 66 | AstraZeneca Pharmaceuticals LP ($275.59) |
| 2018 | $618.35 | 47 | Novo Nordisk Inc ($167.75) |
| 2017 | $1,263 | 102 | Boehringer Ingelheim Pharmaceuticals, Inc. ($221.79) |
All Payment Transactions
793 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $99.91 | General |
| Category: VACCINES | ||||||
| 12/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: Obesity | ||||||
| 09/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,969 | 4,054 | $424,034 | $108,167 |
| 2022 | 33 | 3,061 | 4,044 | $423,387 | $105,397 |
| 2021 | 38 | 3,313 | 4,376 | $449,117 | $129,574 |
| 2020 | 34 | 3,280 | 4,304 | $393,559 | $91,588 |
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 464 | $80,900 | $27,661 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 371 | $90,895 | $25,703 | 28.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 269 | 347 | $29,842 | $5,701 | 19.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $6,175 | $5,271 | 85.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 139 | 176 | $43,375 | $5,029 | 11.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 270 | 363 | $32,670 | $4,743 | 14.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 310 | 539 | $10,915 | $4,528 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $8,140 | $4,403 | 54.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 276 | 376 | $39,480 | $3,885 | 9.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $3,550 | $3,377 | 95.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 20 | $5,600 | $3,164 | 56.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 269 | 323 | $15,504 | $2,458 | 15.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 123 | 191 | $11,651 | $1,818 | 15.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $1,785 | $1,505 | 84.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 67 | 67 | $5,293 | $1,268 | 23.9% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 11 | 14 | $2,800 | $1,132 | 40.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 26 | $4,030 | $984.86 | 24.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $990.00 | $649.22 | 65.6% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 25 | 27 | $1,917 | $618.77 | 32.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 53 | 69 | $6,072 | $572.01 | 9.4% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 20 | 20 | $1,420 | $418.95 | 29.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 30 | 32 | $1,424 | $416.26 | 29.2% |
| 87088 | Bacterial urine culture | Office | 2023 | 39 | 52 | $2,184 | $412.36 | 18.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 88 | 122 | $3,416 | $379.42 | 11.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 38 | $2,888 | $327.30 | 11.3% |
About Dr. Gregory Richter, MD
Dr. Gregory Richter, MD is a Family Medicine healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518967181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Richter, MD has received a total of $11,589 in payments from pharmaceutical and medical device companies, with $2,030 received in 2024. These payments were reported across 793 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,583).
As a Medicare-enrolled provider, Richter has provided services to 12,623 Medicare beneficiaries, totaling 16,778 services with total Medicare billing of $434,726. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Texarkana, TX
- Active Since 07/26/2005
- Last Updated 07/14/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518967181
Products in Payments
- FARXIGA (Drug) $827.84
- QULIPTA (Drug) $530.46
- BREZTRI (Drug) $496.73
- ELIQUIS (Drug) $472.52
- Vascepa (Drug) $460.76
- VRAYLAR (Drug) $448.64
- TRELEGY ELLIPTA (Drug) $447.38
- UBRELVY (Drug) $410.64
- TRULICITY (Drug) $397.89
- XARELTO (Drug) $359.08
- Ozempic (Drug) $319.51
- EVENITY (Biological) $318.60
- JARDIANCE (Drug) $287.20
- EMGALITY (Drug) $280.59
- MOUNJARO (Drug) $279.81
- BELSOMRA (Drug) $243.42
- TRADJENTA (Drug) $233.58
- JANUVIA (Drug) $220.12
- SHINGRIX (Biological) $193.34
- Victoza (Drug) $188.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Texarkana
Dr. Claudia Jordan, M.d, M.D
Family Medicine — Payments: $9,473
Paul Gardial, M.d, M.D
Family Medicine — Payments: $8,603
Dr. Blane Graves, Md, MD
Family Medicine — Payments: $8,027
Herman Kile, Md, MD
Family Medicine — Payments: $7,630
Mr. James Sarrett, Md, MD
Family Medicine — Payments: $7,382
Kevin O'sullivan, M.d, M.D
Family Medicine — Payments: $6,155